ALLERGAN
One of the world ’ s leading pharmaceutical companies has undergone a major logistics ’ transformation as it has grown exponentially through acquisition
The growth of Allergan has led to an overhaul of its logistics operation
Allergan PLC , one of the largest pharmaceutical companies in the world , has undergone a metamorphosis of behemoth proportions in the past three years which has necessitated a major overhaul of its logistics operation .
In March this year , Allergan was acquired by NYSE-listed Actavis creating a $ 23 billion diversified global pharmaceutical company and a leader in the new industry model , Growth Pharma . The deal brought together businesses now extending across 100 countries boasting more than 40 manufacturing plants .
Allergan has a brand portfolio featuring seven blockbuster franchises in key therapeutic categories including : Dermatology and Aesthetics , Eye Care and Women ’ s Health and Urology , while it ’ s Generics portfolio comprises more than 1,000 generics , branded generics , established brands and OTC products and is the third largest generic manufacturer in the US .
Just three months after conclusion of the Allergan deal , the emerging butterfly is shedding it skin with the announcement that Israeli company Teva Pharmaceuticals Industries Ltd has agreed to purchase Allergan ’ s Generics portfolio in a transaction valued at $ 40.5 billion .
Val Pétursson , Allergan ’ s Managing Director of International Logistics , said : “ Teva ’ s offer was simply too good to refuse and the company made the strategic decision to focus on branded products .”
60 November 2015